ABBV vs UNH: AbbVie Inc. vs UnitedHealth Group Incorporated
Side-by-side snapshot of two Healthcare companies — key metrics from our latest data. Reference only, not investment advice.
| Metric | ABBV | UNH |
|---|---|---|
| Company | AbbVie Inc. | UnitedHealth Group Incorporated |
| Price | $254.49 | $426.09 |
| Market Cap | $449.63B | $386.95B |
| P/E Ratio | 124.75 | 32.06 |
| EPS | $2.04 | $13.29 |
| Dividend Yield | 2.72% | 2.18% |
| 52-Week High | $261.64 | $461.62 |
| 52-Week Low | $184.63 | $234.60 |
| Industry | Drug Manufacturers - General | Healthcare Plans |
| Exchange | NYQ | NYQ |
| Employees | 57,000 | 390,000 |
AbbVie Inc. and UnitedHealth Group Incorporated both operate in the Healthcare sector. ABBV trades at a market cap of $449.63B against UNH's $386.95B. Valuation-wise, ABBV carries a trailing P/E of 124.75 versus 32.06 for UNH. How these figures compare depends on each company's growth profile, margins and outlook — the snapshot above is a starting point for further research, not a recommendation.
Figures are from our latest data snapshot and may not reflect current market prices. See the full profiles: AbbVie Inc. and UnitedHealth Group Incorporated. This is not financial advice.
Recommended Reading & Tools
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Keep budgets, portfolios and goals in one place with a dedicated finance planner.
Check Price →JL Collins' plain-English guide to index investing and financial independence.
Check Price →Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: